Search research articles
Contact Us
Filters
Showing results (211-220 of 265) with videos related to
Page
of 27
Sort By:
Journal of the National Cancer Institute
|
May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study
Ryan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J Overman, Sara Lonardi, Ka Yeung Mark Wong, et al.
Bone Marrow Transplantation
|
January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
Rohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Journal of the National Cancer Institute
|
July 1, 2026
A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study
Cecilia G Ethun, Colin M Court, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2024
The Landscape of ctDNA in Appendiceal Adenocarcinoma
Michael G White, Mohammad A Zeineddine, Eleanor A Fallon, et al.
Cancer Research Communications
|
August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials
Esther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Molecular Psychiatry
|
June 24, 2015
Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
Z Tan, W Dai, T G M van Erp, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study
G Mazzoli, F Nichetti, K Shitara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With <i>RAS/BRAF</i> Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 265) with videos related to
Sort By:
Page
of 27
Journal of the National Cancer Institute
|
May 18, 2023
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study
Ryan W Huey, Aakash Tushar Shah, Honey V Reddi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Michael J Overman, Sara Lonardi, Ka Yeung Mark Wong, et al.
Bone Marrow Transplantation
|
January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
Rohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Journal of the National Cancer Institute
|
July 1, 2026
A novel classification of small bowel adenocarcinoma based on the hidden genome classifier: a multi-institutional study
Cecilia G Ethun, Colin M Court, Joanne F Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 16, 2024
The Landscape of ctDNA in Appendiceal Adenocarcinoma
Michael G White, Mohammad A Zeineddine, Eleanor A Fallon, et al.
Cancer Research Communications
|
August 5, 2024
Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials
Esther J Beck, Alexander D Sherry, Marcus A Florez, et al.
Molecular Psychiatry
|
June 24, 2015
Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
Z Tan, W Dai, T G M van Erp, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study
G Mazzoli, F Nichetti, K Shitara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2025
Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With <i>RAS/BRAF</i> Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan, et al.
Page
of 27